Friday, April 1, 2016

UPDATE 1-Amicus gets positive EU recommendation for Fabry disease drug

April 1 (Reuters) - The European Medicines Agency recommended approving American biotech drug developer Amicus Therapeutics Inc's experimental Fabry disease treatment.

Read more

No comments:

Post a Comment